Switches between biosimilars and their reference products

被引：0
|
作者：
Schrieber, Sarah
机构：
来源：
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL | 2023年 / 12卷 / 03期
关键词：
D O I：
10.5639/gabij.2023.1203.016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：40
相关论文
共 50 条
  • [1] Are Biosimilars Identical to the Reference Products?
    Dadashzadeh, Simin
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2009, 8 (02): : 77 - 78
  • [2] Biosimilars in oncology: a therapeutic alternative to the reference products?
    Ludwig, W. D.
    Dicheva, S.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (11): : 1223 - 1229
  • [3] Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases
    Gils, Ann
    Bertolotto, Antonio
    Mulleman, Denis
    Bejan-Angoulvant, Theodora
    Declerck, Paul J.
    THERAPEUTIC DRUG MONITORING, 2017, 39 (04) : 308 - 315
  • [4] Intended use of Reference Products & WHO International Standards/Reference Reagents in the development of Similar Biological Products (Biosimilars)
    Thorpe, Robin
    Wadhwa, Meenu
    BIOLOGICALS, 2011, 39 (05) : 262 - 265
  • [5] THE SAFETY OF SWITCHING BETWEEN REFERENCE BIOPHARMACEUTICALS AND BIOSIMILARS: A SYSTEMATIC REVIEW
    Barbier, L.
    Ebbers, H.
    Simoens, S.
    Declerck, P.
    Vulto, A.
    Huys, I
    VALUE IN HEALTH, 2018, 21 : S309 - S309
  • [6] Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans
    Chambers, James D.
    Lai, Rachel C.
    Margaretos, Nikoletta M.
    Panzer, Ari D.
    Cohen, Joshua T.
    Neumann, Peter J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (19): : 1972 - 1973
  • [7] CHANGES IN THE PRICES OF REFERENCE BIOTECHNOLOGY PRODUCTS BY THE PENETRATION OF BIOSIMILARS INTO THE TURKISH PHARMACEUTICAL MARKET
    Tuna, E.
    Kockaya, G.
    VALUE IN HEALTH, 2015, 18 (07) : A535 - A535
  • [8] A Retrospective Analysis of the Potential Impact of Differences in Aggregates on Clinical Immunogenicity of Biosimilars and their Reference Products
    Fernandez-Mendivil, Cristina
    Kinsella, Niamh M.
    Ebbers, Hans C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (05) : 1122 - 1131
  • [9] The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review
    Barbier, Liese
    Ebbers, Hans C.
    Declerck, Paul
    Simoens, Steven
    Vulto, Arnold G.
    Huys, Isabelle
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (04) : 734 - 755
  • [10] BIOSIMILARS AND REFERENCE PRICE GROUPS IN GERMANY
    Eheberg, D.
    Pointner, J.
    Antoni, B.
    Gossmann, J. A.
    Batscheider, A.
    VALUE IN HEALTH, 2016, 19 (07) : A468 - A468
12345